SLC19A3 Antibody

Western Blot: SLC19A3 Antibody [NBP1-69703] - Expression of adipose-specific genes and adipose-enhanced genes. Semi-quantitative RT-PCR and/or Western blot analysis (WB) of CSN1S1, SLC19A3, and LVRN (AQPEP) in selected tissues: subcutaneous adipose tissue (Ad), brain (Br), heart (He), kidney (Ki), lung (Lu), liver (Li), and skeletal muscle (Mu). Target sizes for RT-PCR: 213 bp (CSN1S1), 170 bp (SLC19A3) and 193 bp (LVRN (AQPEP)). Expected sizes for full-length proteins were 21.7 kDa and 55.7 kDa for CSN1S1 and SLC19A3, respectively. Cyclophilin (CYC) (325 bp) and GAPDH (38 kDa) were used as a reference gene and protein, respectively.

Western Blot: SLC19A3 Antibody [NBP1-69703] - Expression of adipose-specific genes and adipose-enhanced genes. Semi-quantitative RT-PCR and/or Western blot analysis (WB) of CSN1S1, SLC19A3, and LVRN (AQPEP) in selected tissues: subcutaneous adipose tissue (Ad), brain (Br), heart (He), kidney (Ki), lung (Lu), liver (Li), and skeletal muscle (Mu). Target sizes for RT-PCR: 213 bp (CSN1S1), 170 bp (SLC19A3) and 193 bp (LVRN (AQPEP)). Expected sizes for full-length proteins were 21.7 kDa and 55.7 kDa for CSN1S1 and SLC19A3, respectively. Cyclophilin (CYC) (325 bp) and GAPDH (38 kDa) were used as a reference gene and protein, respectively.

Western Blot: SLC19A3 Antibody [NBP1-69703] - Expression of adipose-specific genes and adipose-enhanced genes. Semi-quantitative RT-PCR and/or Western blot analysis (WB) of CSN1S1, SLC19A3, and LVRN (AQPEP) in selected tissues: subcutaneous adipose tissue (Ad), brain (Br), heart (He), kidney (Ki), lung (Lu), liver (Li), and skeletal muscle (Mu). Target sizes for RT-PCR: 213 bp (CSN1S1), 170 bp (SLC19A3) and 193 bp (LVRN (AQPEP)). Expected sizes for full-length proteins were 21.7 kDa and 55.7 kDa for CSN1S1 and SLC19A3, respectively. Cyclophilin (CYC) (325 bp) and GAPDH (38 kDa) were used as a reference gene and protein, respectively.